Biopharmaceuticals Manufacturing Consumables Testing Market Report

Biopharmaceuticals Manufacturing Consumables Testing Market Analysis Report By Service (Compendial Testing, Laboratory Testing), By Raw Material Type (Excipients, API), And Segment Forecasts, 2018 - 2025

  • Published Date: Jul, 2018
  • Base Year for Estimate: 2017
  • Report ID: GVR-2-68038-398-0
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2017
  • Number of Pages: 139

Industry Insights

The global biopharmaceuticals manufacturing consumables testing market size was valued at USD 284.80 million in 2017 and is projected to expand at a CAGR of 12.1% during the forecast period. Successful and efficient biopharmaceutical manufacturing is largely dependent on the purity and quality of consumables used during production. With growing issues pertaining to quality of novel therapeutics such as poor solubility, increase in molecular sizes, and poor absorption properties, there is a rise in focus on exploring the various attributes of excipients and other raw materials.

Establishing identity, purity, and quality of raw/starting material is a crucial step in biopharmaceutical manufacturing. This is because any variation in excipient, additives, or API profile with respect to impurity, particle size, dissolution characteristics, and other factors can drastically influence the functioning and performance of the final product.

U.K. biopharmaceuticals manufacturing consumables testing market

Quality standards have gradually evolved to support biologics production. Constant improvement in regulatory standards for biologic production also encompasses use of proper raw materials and their qualification assessment. Regulations and guidance standards with respect to region-specific pharmacopeia have also accelerated raw material investigation to meet the requirements of biopharma manufacturers.

Characterization of raw materials by vendors in co-operation and collaboration with players in the pharma and biopharmaceutical industry helps address issues associated with the manufacturing process, thereby facilitating rapid launch of the final product in the market. These issues include quality-by-design and bioavailability of products. 

Perpetual introduction of new technologies and advancements in existing technologies for efficient large molecule production is one of the key drivers of this market. While some advancements are solely focused on biopharmaceutical production, the industry is also witnessing technological innovations to support thorough quality check based processing, right from raw materials to finished drugs.

Technological advancements in analytical technologies have provided vendors with improved capabilities to test proteins, raw materials, cell lines, and other consumables used during the production of large molecules. Advancements in portable Raman spectroscopy methods is one of the significant developments in this market. Agilent Technologies is one of the companies offering products based on the principle of Raman spectroscopy.

Service Insights

There are various services offered in the biopharma sector to ensure purity and safety of consumables. Compendial and multi-compendial laboratory testing accounted for the largest share in 2017 owing to presence of numerous providers offering services in compliance with various compendia. Presence of region-specific pharmacopeias compels companies to perform full-monograph testing, which has been observed to be expensive, contributing to the high revenue of this segment.

Custom testing/customer proprietary testing witnessed the lowest market penetration in 2017. This is due to presence of relatively fewer services in this segment. However, changing customer requirements and need for specific analysis for excipients are expected to lend this segment a much-needed boost in the coming years.

Raw Material Insights

By raw material, the biopharmaceuticals manufacturing consumables testing market is segmented into formulation excipients, Active Pharmaceutical Ingredients (API), and compendial methods (EP / JP / USP) based vendor qualification program support. API investigation services accounted for the largest revenue share in 2017 whereas compendial methods-based vendor qualification program support is anticipated to grow at a lucrative pace in the coming years. 

API assessment is a routine testing process in biopharma manufacturing. However, API characterization for biologic molecules is relatively more difficult and time-consuming as compared to synthetic APIs.

Global biopharmaceuticals manufacturing consumables testing market

Rapid growth of the biopharma industry has made it necessary to keep pace with changing or improving regulatory requirements for analysis of raw materials required during biologics manufacturing. As a result, final product manufacturers seek vendor qualification program support to validate if services offered by the vendor comply with compendial monographs. This has driven the segment for compendial methods-based vendor qualification program support.

Regional Insights

North America dominated the market in 2017 with respect to revenue owing to presence of substantial number of biopharmaceutical manufacturing facilities in U.S. Furthermore, effective regulations pertaining to biopharmaceutical production and approval in the country has contributed to the large share of North America in the global market.

Asian countries, with China and India at the forefront, are expected to emerge as lucrative sources of revenue in the coming years. This is due to improving biopharmaceutical industry in the region as well as shift in attention of international companies toward the Asian market for outsourcing options.

Biopharmaceuticals Manufacturing Consumables Testing Market Share Insights

Alcami Corporation; Merck KGaA; Eurofins Scientific; Agilent Technologies; Charles River; Catalent, Inc.; Avomeen Analytical Services; BioSpectra; and Pace Analytical Services, LLC are some service providers engaged in providing services for consumables testing in the biopharmaceutical industry. Other key participants include Gibraltar Laboratories; Pacific BioLabs; Toxikon, Inc.; Activation Laboratories Ltd.; MabPlex Inc.; SGS SA; Pharmetric Laboratory; Albany Molecular Research Inc.; Avance Biosciences; Triclinic Labs; Lonza; Boston Analytical; and STERIS.

These service providers are engaged in strategic alliances with several prominent biopharmaceutical companies across the globe. They are making focused attempts to meet changing regulatory requirements and fulfilling rising demand.

Report Scope

Attribute

Details

Base year for estimation

2017

Actual estimates/Historical data

2014 - 2017

Forecast period

2018 - 2025

Market representation

Revenue in USD Million and CAGR from 2018 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country scope

U.S., Canada, Germany, U.K., China, India, Brazil, South Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5-analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global biopharmaceuticals manufacturing consumables testing market report on the basis of service, raw material type, and region:

  • Service Outlook (Revenue, USD Million, 2014 - 2025)

    • Laboratory Testing

      • Chemical Analysis Testing

      • Enzyme Testing

      • Stability Testing

      • Sterility Testing

      • Others

    • Custom Testing / Customer Proprietary Testing

    • Compendial & Multi Compendial Laboratory Testing

  • Raw Material Type Outlook (Revenue, USD Million, 2014 - 2025)

    • Formulation Excipients

    • Active Pharmaceutical Ingredients (API)

    • Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • China

      • India

    • Latin America

      • Brazil

    • Middle East & Africa

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $6,950
Enterprise Access - $8,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified